Latest Insider Transactions at Medtronic PLC (MDT)
This section provides a real-time view of insider transactions for Medtronic PLC (MDT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Medtronic plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Medtronic plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 07
2019
|
Omar Ishrak Executive Chairman |
SELL
Bona fide gift
|
Indirect |
4,100
-41.0%
|
-
|
|
Oct 01
2019
|
Robert John White EVP & Pres. Medical Surgical |
SELL
Sale (or disposition) back to the issuer
|
Direct |
52,165
-10.54%
|
$5,633,820
$108.88 P/Share
|
|
Oct 01
2019
|
Robert John White EVP & Pres. Medical Surgical |
BUY
Exercise of conversion of derivative security
|
Direct |
52,165
+16.32%
|
$1,408,455
$27.41 P/Share
|
|
Sep 27
2019
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Open market or private sale
|
Direct |
21,425
-10.7%
|
$2,292,475
$107.86 P/Share
|
|
Sep 25
2019
|
James T Lenehan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
744
-1.34%
|
$79,608
$107.62 P/Share
|
|
Sep 25
2019
|
James T Lenehan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,813
+3.17%
|
$79,772
$44.13 P/Share
|
|
Sep 10
2019
|
Hooman Hakami EVP & Group President Diabetes |
SELL
Open market or private sale
|
Direct |
82,877
-19.25%
|
$8,867,839
$107.26 P/Share
|
|
Sep 10
2019
|
Hooman Hakami EVP & Group President Diabetes |
BUY
Exercise of conversion of derivative security
|
Direct |
72,877
+13.8%
|
$6,121,668
$84.78 P/Share
|
|
Aug 05
2019
|
Bradley E Lerman SVP General Counsel & Corp Sec |
SELL
Open market or private sale
|
Direct |
4,000
-7.03%
|
$400,000
$100.31 P/Share
|
|
Aug 02
2019
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Open market or private sale
|
Direct |
5,719
-5.4%
|
$583,338
$102.02 P/Share
|
|
Aug 02
2019
|
Bradley E Lerman SVP General Counsel & Corp Sec |
SELL
Open market or private sale
|
Direct |
6,599
-10.39%
|
$673,098
$102.02 P/Share
|
|
Aug 01
2019
|
Michael J Coyle EVP & Group Pres, Cardiac&Vasc |
SELL
Payment of exercise price or tax liability
|
Direct |
29,689
-7.0%
|
$3,028,278
$102.37 P/Share
|
|
Aug 01
2019
|
Hooman Hakami EVP & Group President Diabetes |
SELL
Payment of exercise price or tax liability
|
Direct |
10,265
-10.61%
|
$1,047,030
$102.37 P/Share
|
|
Aug 01
2019
|
Omar Ishrak Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
24,894
-3.99%
|
$2,539,188
$102.37 P/Share
|
|
Aug 01
2019
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Payment of exercise price or tax liability
|
Direct |
4,795
-4.33%
|
$489,090
$102.37 P/Share
|
|
Aug 01
2019
|
Bradley E Lerman SVP General Counsel & Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
5,533
-8.01%
|
$564,366
$102.37 P/Share
|
|
Aug 01
2019
|
John R Liddicoat EVP & President of Americas |
SELL
Payment of exercise price or tax liability
|
Direct |
9,942
-10.43%
|
$1,014,084
$102.37 P/Share
|
|
Aug 01
2019
|
Geoffrey Martha Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,775
-8.29%
|
$997,050
$102.37 P/Share
|
|
Aug 01
2019
|
Karen L Parkhill EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,533
-6.09%
|
$564,366
$102.37 P/Share
|
|
Aug 01
2019
|
Carol A Surface EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,058
-9.71%
|
$413,916
$102.37 P/Share
|
|
Aug 01
2019
|
Hoedt Rob Ten EVP and Pres. Global Regions |
SELL
Payment of exercise price or tax liability
|
Direct |
8,087
-6.13%
|
$824,874
$102.37 P/Share
|
|
Aug 01
2019
|
Robert John White EVP & Pres. Medical Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
8,182
-7.03%
|
$834,564
$102.37 P/Share
|
|
Jul 29
2019
|
Michael J Coyle EVP & Group Pres, Cardiac&Vasc |
BUY
Grant, award, or other acquisition
|
Direct |
14,850
+6.39%
|
-
|
|
Jul 29
2019
|
Hooman Hakami EVP & Group President Diabetes |
BUY
Grant, award, or other acquisition
|
Direct |
8,071
+13.66%
|
-
|
|
Jul 29
2019
|
Omar Ishrak Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
45,194
+6.76%
|
-
|
|
Jul 29
2019
|
Richard Kuntz SVP & Chief Medical & Science |
BUY
Grant, award, or other acquisition
|
Direct |
10,330
+8.53%
|
-
|
|
Jul 29
2019
|
Bradley E Lerman SVP General Counsel & Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
10,330
+13.02%
|
-
|
|
Jul 29
2019
|
John R Liddicoat EVP & President of Americas |
BUY
Grant, award, or other acquisition
|
Direct |
6,134
+11.11%
|
-
|
|
Jul 29
2019
|
Geoffrey Martha Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
12,267
+16.65%
|
-
|
|
Jul 29
2019
|
Karen L Parkhill EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,204
+13.51%
|
-
|
|
Jul 29
2019
|
Carol A Surface EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,425
+15.09%
|
-
|
|
Jul 29
2019
|
Hoedt Rob Ten EVP and Pres. Global Regions |
BUY
Grant, award, or other acquisition
|
Direct |
9,039
+11.73%
|
-
|
|
Jul 29
2019
|
Robert John White EVP & Pres. Medical Surgical |
BUY
Grant, award, or other acquisition
|
Direct |
11,622
+16.2%
|
-
|
|
Jul 22
2019
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Open market or private sale
|
Direct |
3,438
-3.32%
|
$347,238
$101.12 P/Share
|
|
Jun 21
2019
|
Karen L Parkhill EVP & Chief Financial Officer |
BUY
Bona fide gift
|
Indirect |
900
+50.0%
|
-
|
|
Jun 21
2019
|
Karen L Parkhill EVP & Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
900
-1.16%
|
-
|
|
Jun 20
2019
|
Karen L Parkhill EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,945
-8.23%
|
$687,555
$99.26 P/Share
|
|
Jun 17
2019
|
Carol A Surface EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
9,000
-20.85%
|
$873,000
$97.66 P/Share
|
|
Jun 12
2019
|
Hooman Hakami EVP & Group President Diabetes |
SELL
Open market or private sale
|
Direct |
52,664
-33.1%
|
$5,108,408
$97.49 P/Share
|
|
Jun 12
2019
|
Hooman Hakami EVP & Group President Diabetes |
BUY
Exercise of conversion of derivative security
|
Direct |
31,731
+24.97%
|
$2,475,018
$78.0 P/Share
|
|
Jun 06
2019
|
Geoffrey Martha Chairman and CEO |
SELL
Open market or private sale
|
Direct |
11,000
-18.36%
|
$1,056,000
$96.05 P/Share
|
|
May 28
2019
|
Hoedt Rob Ten EVP and Pres. Global Regions |
SELL
Open market or private sale
|
Direct |
9,000
-13.28%
|
$819,000
$91.88 P/Share
|
|
May 24
2019
|
Richard H Anderson Director |
BUY
Open market or private purchase
|
Direct |
10,900
+10.81%
|
$1,002,800
$92.4 P/Share
|
|
Apr 30
2019
|
Richard H Anderson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
429
-0.54%
|
$37,752
$88.81 P/Share
|
|
Apr 30
2019
|
Craig Arnold Director |
SELL
Payment of exercise price or tax liability
|
Direct |
429
-1.38%
|
$37,752
$88.81 P/Share
|
|
Apr 30
2019
|
Scott C Donnelly Director |
SELL
Payment of exercise price or tax liability
|
Direct |
429
-3.78%
|
$37,752
$88.81 P/Share
|
|
Apr 30
2019
|
Randall J Hogan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
429
-1.14%
|
$37,752
$88.81 P/Share
|
|
Apr 30
2019
|
James T Lenehan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
429
-0.8%
|
$37,752
$88.81 P/Share
|
|
Apr 30
2019
|
Denise M Oleary Director |
SELL
Payment of exercise price or tax liability
|
Direct |
429
-0.66%
|
$37,752
$88.81 P/Share
|
|
Apr 30
2019
|
Elizabeth G Nabel Director |
SELL
Payment of exercise price or tax liability
|
Direct |
429
-5.08%
|
$37,752
$88.81 P/Share
|